Dexcom (DXCM) Other financing activities (2018 - 2026)

Dexcom (DXCM) has 9 years of Other financing activities data on file, last reported at -$1.9 million in Q1 2026.

• Other financing activities for Q1 2026 came in at -$1.9 million, down 11.76% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.2 million (down 20.0% YoY), and the FY2025 annual result was -$7.0 million, up 46.15% from the prior year.
• Other financing activities steadied at -$1.9 million in Q1 2026 per DXCM's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Other financing activities peaked at $4.9 million in Q4 2023 and troughed at -$8.7 million in Q1 2024.
• A 5-year average of -$2.2 million and a median of -$1.7 million in 2025 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2023: Other financing activities tumbled 975.0% in 2022, then jumped 590.0% in 2023.
• A 5-year view of Other financing activities shows it stood at -$1.0 million in 2022, then jumped by 590.0% to $4.9 million in 2023, then slumped by 132.65% to -$1.6 million in 2024, then declined by 18.75% to -$1.9 million in 2025, then changed by 0.0% to -$1.9 million in 2026.
• Business Quant data shows DXCM's Other financing activities at -$1.9 million in Q1 2026, -$1.9 million in Q4 2025, and -$1.7 million in Q3 2025.